These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 839788)

  • 21. Evaluation of the effectiveness and safety of a controlled-release theophylline in patients with reversible and stable bronchial obstruction.
    Grassi V; Nicora M; Beretta A
    Int J Clin Pharmacol Res; 1987; 7(5):337-44. PubMed ID: 3667006
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Bronchospasmolytic effectiveness of controlled drug combinations].
    Forche G; Zenker G; Harnoncourt K
    Wien Med Wochenschr; 1986 May; 136(9):213-8. PubMed ID: 3739357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aminophylline injection, USP (theophylline ethylenediamine).
    Sjrogren ER
    Crit Care Nurse; 1983; 3(2):68-9. PubMed ID: 6551212
    [No Abstract]   [Full Text] [Related]  

  • 24. [The effect of microencapsulation on the pharmacological activity of theophylline and euphylline].
    Andreeva IN; Saraf AS; Makarov VA
    Farmakol Toksikol; 1991; 54(5):27-9. PubMed ID: 1800140
    [No Abstract]   [Full Text] [Related]  

  • 25. Dangers of compound drugs and intravenous aminophylline.
    Thompson PJ; Hay JG
    Lancet; 1982 Nov; 2(8309):1228. PubMed ID: 6128542
    [No Abstract]   [Full Text] [Related]  

  • 26. [Possibilities for optimizing therapy with theophylline preparations. III. Ventilatory effect and pharmacokinetics of "new" Pulmophyllin].
    Kandt D; Sehrt I; Iwainsky H
    Z Erkr Atmungsorgane; 1984; 162(1):18-25. PubMed ID: 6719956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Criteria for use of theophylline (aminophylline) in inpatients and outpatients with pulmonary disease.
    Phillips MS
    Clin Pharm; 1992 Dec; 11(12):1033-8. PubMed ID: 1286554
    [No Abstract]   [Full Text] [Related]  

  • 28. [Principles of theophylline therapy in obstructive respiratory diseases].
    Ukena D; Sybrecht GW
    Pneumologie; 1992 Feb; 46(2):49-51. PubMed ID: 1549553
    [No Abstract]   [Full Text] [Related]  

  • 29. [Practicability, effectiveness and tolerance of a standardized prepared theophylline infusion].
    Pohl WR; Kummer F; Lorber H; Würtz J; Aigner K; Pfeiffer KP
    Acta Med Austriaca; 1996; 23(3):105-8. PubMed ID: 8967286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of theophylline. Application to adjustment of the clinical dose of aminophylline.
    Jenne JW; Wyze MS; Rood FS; MacDonald FM
    Clin Pharmacol Ther; 1972; 13(3):349-60. PubMed ID: 5026376
    [No Abstract]   [Full Text] [Related]  

  • 31. Influenza vaccine may enhance theophylline toxicity. A case report and review of the literature.
    Hamdy RC; Micklewright M; Beecham VF; Moore SW
    J Tenn Med Assoc; 1995 Dec; 88(12):463-4. PubMed ID: 8531477
    [No Abstract]   [Full Text] [Related]  

  • 32. [Evaluation of drugs for the treatment of chronic obstructive lung diseases--analysis of bronchospasmolytics/antiasthmatics of the Red List 1984].
    Overbeck J; Fabel H
    Prax Klin Pneumol; 1985 Dec; 39(12):957-61. PubMed ID: 4095075
    [No Abstract]   [Full Text] [Related]  

  • 33. The use of theophylline clearance to design an oral aminophylline regimen.
    Simmons SM; Camp RB; Mungall DR; Bailey WC
    Ala J Med Sci; 1982 Apr; 19(2):142-6. PubMed ID: 7102998
    [No Abstract]   [Full Text] [Related]  

  • 34. [Comparison of two long-acting theophylline preparations in daily evening administration].
    Holzer R
    Wien Med Wochenschr; 1993; 143(2):37-42. PubMed ID: 8488685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Theophylline derivatives in obstructive pulmonary disorders].
    Hauge HE; Gamst ON
    Tidsskr Nor Laegeforen; 1967 Mar; 87(6):535-8. PubMed ID: 6047180
    [No Abstract]   [Full Text] [Related]  

  • 36. Letter: Management of asthma.
    N Engl J Med; 1974 Oct; 291(16):848-9. PubMed ID: 4419986
    [No Abstract]   [Full Text] [Related]  

  • 37. [The comparative efficacy of the prolonged-action theophylline preparations Theopek and Euphylong in elderly patients with chronic obstructive lung diseases].
    Salikova VV; Nonikov VE; Belousov IuB
    Ter Arkh; 1993; 65(8):41-4. PubMed ID: 8211801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Therapeutic non-compliance in patients with chronic airway obstruction].
    Barrueco M; Otero MJ; Fernández de Gatta MR; Martín J; de Portugal J; Domínguez-Gil A
    Rev Clin Esp; 1987 Apr; 180(6):293-5. PubMed ID: 3602534
    [No Abstract]   [Full Text] [Related]  

  • 39. Theophylline in asthma and COPD: changing perspectives and controversies.
    Poe RH; Utell MJ
    Geriatrics; 1991 Apr; 46(4):55-6, 61-5. PubMed ID: 2010095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prescription of Theostat 300 as a single evening dose].
    Germouty J; Bida C; Moreau L
    Rev Pneumol Clin; 1987; 43(5):262-5. PubMed ID: 3324266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.